pillbase.ru

Simponi

Active substance: golimumab

INJECTION, SOLUTION · GOLIMUMAB 50 mg/.5mL

United StatesActive

Marketing holder: Janssen Biotech, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 3
  • Симпони®
    раствор для подкожного введения, 50 мг, 0.5 мл (original in Russian, GRLS)
    ЛП-№(009539)-(РГ-RU)
    ООО "Джонсон & Джонсон"
  • Симпони®
    раствор для подкожного введения, 50 мг/0.5 мл, 0.5 мл (original in Russian, GRLS)
    ЛП-001686
    ООО "Джонсон & Джонсон"
  • Симпони®
    раствор для подкожного введения, 100 мг/мл, 1 мл (original in Russian, GRLS)
    ЛП-003825
    ООО "МСД Фармасьютикалс"
EU 3
  • Gobivaz
    golimumab
    EMEA/H/C/006560
    Advanz Pharma Limited
  • Gotenfia
    golimumab
    EMEA/H/C/006621
    Stada Arzneimittel AG
  • Simponi
    golimumab
    EMEA/H/C/000992
    Janssen Cilag International NV
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-a685-7552-82fa-8b5feccf8999,01a120c4-b7d8-7c86-8301-5f0c929f3173,01a120c5-a6a1-78ee-959a-54c784ccdc90;count=3 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12098-d6ca-7d8d-be9e-3582cf2ce7cc,01a12098-d6d2-784c-baaf-55afea5f162c,01a1209b-4806-7c26-aa43-3ce6f97ef48d;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
57894-070
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 57894-070 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 57894-070 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 57894-070 · Verified 2026-10-09 · open in source